NVIM
ABBV icon

New Vernon Investment Management’s AbbVie ABBV Stock Holding History

New Vernon Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-25,700
Closed -$1.95M – 39
2019
Q3 		$1.95M Buy
+25,700
New +$1.76M 4.08% 10

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

New Vernon Investment Management's ABBV Position: Q4 2019 in Review

New Vernon Investment Management sold out of AbbVie (ABBV) in Q4 2019, closing a stake of 25,700 shares — an estimated $1.95M sold.

New Vernon Investment Management first reported a position in ABBV in Q3 2019 and held it in 1 quarter. The position peaked at $1.95M in Q3 2019. 2,244 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

  • New Vernon Investment Management reported no remaining AbbVie position as of Q4 2019 after selling out during the quarter.
  • New Vernon Investment Management sold 25,700 AbbVie shares in Q4 2019, an estimated $1.95M.
  • New Vernon Investment Management first reported a position in AbbVie in Q3 2019 and held it in 1 quarter.
  • New Vernon Investment Management's AbbVie position peaked at $1.95M in Q3 2019.
  • 2,244 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on New Vernon Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.